PRNewsWire
11 Jun 2026, 06:17 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Zoetis Inc. is facing a securities fraud class action lawsuit alleging the company made false and misleading statements regarding its product performance. — Lawsuits alleging securities fraud create significant legal uncertainty and potential for large financial settlements, typically weighing on stock price.
-0.60Librela experienced weakening prescription growth following FDA safety warnings about neurological complications in dogs. — FDA safety warnings on a key product can lead to permanent loss of market share and reduced long-term revenue projections.
-0.50Zoetis's Trio, Apoquel, and Cytopoint products have lost market share to new competing treatments. — Loss of market share across multiple product lines indicates eroding competitive advantages and pricing power.
-0.40Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
The company is mentioned as the subject of a securities fraud lawsuit.
The company is facing a securities fraud class action lawsuit alleging false statements regarding product market share and safety warnings.
The company is mentioned as the subject of a securities fraud lawsuit.
Go deeper
You just saw which tickers this one story hits. A free account turns that into a standing screen: the movers delivered on schedule, before the chart catches up.
On this page · free
In the platform
Free account, 30 seconds. No credit card. Covers all 20 tickers this story moves.
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
Screener bridge
Catch the names this kind of story moves — before the chart does.
Get the full NIS Momentum results every Friday at 4PM ET — free via email or Telegram.
PRNewsWire
9h ago
